OPTIMIRA
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

OPTIMIRA Trademark

Serial Number: 77396174

OPTIMIRA is a trademark filed by BAYER SCHERING PHARMA AKTIENGESELLSCHAFT on February 13, 2008. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (240 trademarks)

MULLERSTRASSE 178
BERLIN 13353 , DE

Entity Type: 07

Direvo BioTech AG (8 trademarks)

Nattermannallee 1
D-50829 Koln , DE

Entity Type: 03

Trademark Details

Filing Date

February 13, 2008

Registration Date

Not Registered

Published for Opposition

March 10, 2009

Goods & Services

Pharmaceutical and veterinary preparations and diagnostic agents, with a base of biologically active substances in the nature of proteins and nucleic acids, all for use in treating autoimmune and inflammation diseases, diseases of blood and lymphatic system, cancer, cardiovascular and circulatory diseases, diseases of the central nervous system, dental diseases, dermatology disorders, diseases of the digestive system, genetic diseases, infections, diseases of the kidney and genitourinary system, metabolic diseases, endocrinology diseases, musculoskeletal disorders, ophthalmology diseases, respiratory and pulmonary diseases, and gynecological diseases; medical diagnostic kits comprised of reagents and assays for testing of samples of a human or animal patient, namely, tissue samples, biopsies, body fluids, smears, skin samples, mucosa samples and hair

Chemicals used in industry and science, namely, biologically active substances in the nature of proteins and nucleic acids, having affine and/or enzymatic properties, including enzymes and ribozymes; kits comprised of chemical reagents and assays for use in molecular-biological research

Consultancy and contract research in the field of molecular biology, namely, with regard to the development and optimization of biologically active substances; Custom development of biochemical assay systems on a molecular-biological basis, in particular for research, medicine and environmental analytics; scientific research and development in the field of biologically active substances by means of evolutive biotechnology

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 8, 2011 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 8, 2011 ABN6
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 31, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 31, 2011 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 14, 2011 EXRA
SOU EXTENSION 3 GRANTED
Jan 13, 2011 EX3G
SOU EXTENSION 3 FILED
Dec 21, 2010 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 21, 2010 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 8, 2010 EXRA
SOU EXTENSION 2 GRANTED
Jun 7, 2010 EX2G
SOU EXTENSION 2 FILED
Jun 2, 2010 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 2, 2010 EEXT
SOU EXTENSION 1 GRANTED
Dec 8, 2009 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 8, 2009 AITU
SOU EXTENSION 1 FILED
Nov 6, 2009 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 6, 2009 EEXT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 17, 2009 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 17, 2009 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 16, 2009 ASGN
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 7, 2009 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 25, 2009 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 3, 2009 ETOF
PUBLISHED FOR OPPOSITION
Mar 10, 2009 PUBO
NOTICE OF PUBLICATION
Feb 18, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 2, 2009 PREV
ASSIGNED TO LIE
Jan 30, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 19, 2009 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 19, 2009 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 27, 2008 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 27, 2008 GNSL
SUSPENSION LETTER WRITTEN
Oct 27, 2008 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2008 CRFA
ASSIGNED TO LIE
Oct 17, 2008 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 1, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 30, 2008 GNRN
NON-FINAL ACTION E-MAILED
May 30, 2008 GNRT
NON-FINAL ACTION WRITTEN
May 30, 2008 CNRT
ASSIGNED TO EXAMINER
May 23, 2008 DOCK
NOTICE OF PSEUDO MARK MAILED
Feb 20, 2008 MPMK
NEW APPLICATION ENTERED
Feb 19, 2008 NWAP